Virtus ETF Advisers LLC
- SEC CIK
- 0001587281
- Latest filing
- Aug 11, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 10, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 399
- +44 vs. Q1 2021
- Portfolio value
- $243.2M
- +$6.44M (+2.7%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 353 | $3.00K | <0.1% | +353 | New | History |
| CVMCel Sci Corp | COM PAR NEW | 10,477 | $91.0K | <0.1% | −10,737−50.6% | Reduced | History |
| SPDR Series Trust78468R622 | ST BLOO HIGH ETF | 874 | $96.0K | <0.1% | 00.0% | Unchanged | – |
| LONALeonaBio, Inc. | COM | 11,530 | $118.0K | <0.1% | +11,530 | New | History |
| IRONDisc Medicine, Inc. | COM | 19,673 | $127.0K | 0.1% | +19,673 | New | History |
| ALGSAligos Therapeutics, Inc. | COM | 7,167 | $146.0K | 0.1% | +7,167 | New | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 21,447 | $146.0K | 0.1% | +21,447 | New | History |
| Invesco Exch Traded FD Tr II46138G508 | SR LN ETF | 6,778 | $150.0K | 0.1% | +6,778 | New | – |
| iShares Tr464288513 | IBOXX HI YD ETF | 1,727 | $152.0K | 0.1% | 00.0% | Unchanged | – |
| CDAKCodiak BioSciences, Inc. | COM | 8,755 | $162.0K | 0.1% | +8,755 | New | History |
| Curevac N VN2451R105 | COM | 2,259 | $166.0K | 0.1% | −221−8.9% | Reduced | – |
| BTAIQBioXcel Therapeutics, Inc. | COM | 5,831 | $169.0K | 0.1% | −655−10.1% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 5,589 | $178.0K | 0.1% | −6,792−54.9% | Reduced | History |
| CRDFCardiff Oncology, Inc. | COM | 27,114 | $180.0K | 0.1% | +12,329+83.4% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 4,229 | $180.0K | 0.1% | +394+10.3% | Added | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 6,319 | $183.0K | 0.1% | +6,319 | New | History |
| NUVBNuvation Bio Inc. | COM CL A | 19,604 | $183.0K | 0.1% | +19,604 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 8,697 | $184.0K | 0.1% | +8,697 | New | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 7,642 | $184.0K | 0.1% | +7,642 | New | History |
| BCELAtreca, Inc. | CL A COM | 21,550 | $184.0K | 0.1% | +3,694+20.7% | Added | History |
| FBRXForte Biosciences, Inc. | COM | 5,512 | $185.0K | 0.1% | +5,512 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 7,281 | $187.0K | 0.1% | +7,281 | New | History |
| AKROAkero Therapeutics, Inc. | COM | 7,526 | $187.0K | 0.1% | −2,928−28.0% | Reduced | History |
| RNACCartesian Therapeutics, Inc. | COM | 44,648 | $187.0K | 0.1% | −50,681−53.2% | Reduced | History |
| VORVor Biopharma Inc. | COM | 10,026 | $187.0K | 0.1% | +10,026 | New | History |
| KDNYChinook Therapeutics, Inc. | COM | 13,299 | $188.0K | 0.1% | +13,299 | New | History |
| EVLOEvelo Biosciences, Inc. | COM | 13,690 | $188.0K | 0.1% | +13,690 | New | History |
| HGENHumanigen, Inc | COM NEW | 10,901 | $189.0K | 0.1% | −14,205−56.6% | Reduced | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 7,893 | $189.0K | 0.1% | +7,893 | New | History |
| PRLDPrelude Therapeutics Inc | COM | 6,622 | $190.0K | 0.1% | +6,622 | New | History |
| APLTApplied Therapeutics, Inc. | COM | 9,247 | $192.0K | 0.1% | −3,191−25.7% | Reduced | History |
| CUECue Biopharma, Inc. | COM | 16,448 | $192.0K | 0.1% | −5,605−25.4% | Reduced | History |
| DNTHDianthus Therapeutics, Inc. | COM | 19,673 | $192.0K | 0.1% | +19,673 | New | History |
| RUBYRubius Therapeutics, Inc. | COM | 7,868 | $192.0K | 0.1% | −26,528−77.1% | Reduced | History |
| VXRTVaxart, Inc. | COM NEW | 25,589 | $192.0K | 0.1% | −13,328−34.2% | Reduced | History |
| VSTMVerastem, Inc. | COM | 47,291 | $192.0K | 0.1% | −85,009−64.3% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 2,328 | $194.0K | 0.1% | −1,106−32.2% | Reduced | History |
| LITSLite Strategy, Inc. | COM NEW | 68,197 | $194.0K | 0.1% | −35,526−34.3% | Reduced | History |
| STOKStoke Therapeutics, Inc. | COM | 5,786 | $195.0K | 0.1% | +425+7.9% | Added | History |
| KLRSKalaris Therapeutics, Inc. | COM | 9,854 | $195.0K | 0.1% | +2,376+31.8% | Added | History |
| ORTXOrchard Therapeutics plc | ADS | 44,471 | $195.0K | 0.1% | −21,536−32.6% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 30,896 | $196.0K | 0.1% | −7,125−18.7% | Reduced | History |
| MTEMMolecular Templates, Inc. | COM | 25,049 | $196.0K | 0.1% | −4,196−14.3% | Reduced | History |
| QUREuniQure N.V. | SHS | 6,411 | $197.0K | 0.1% | −56−0.9% | Reduced | History |
| KRTXKaruna Therapeutics, Inc. | COM | 1,728 | $197.0K | 0.1% | −1,458−45.8% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 10,801 | $197.0K | 0.1% | +10,801 | New | History |
| PLRXPliant Therapeutics, Inc. | COM | 6,799 | $198.0K | 0.1% | −4,151−37.9% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 3,442 | $198.0K | 0.1% | −5,486−61.4% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 24,554 | $199.0K | 0.1% | −3,547−12.6% | Reduced | History |
| ABCLAbCellera Biologics Inc. | COM | 9,111 | $200.0K | 0.1% | +9,111 | New | History |
| KURAKura Oncology, Inc. | COM | 9,572 | $200.0K | 0.1% | +2,304+31.7% | Added | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 15,363 | $200.0K | 0.1% | +15,363 | New | – |
| GRTSGritstone bio, Inc. | COM | 21,930 | $200.0K | 0.1% | +21,930 | New | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 75,826 | $200.0K | 0.1% | −21,353−22.0% | Reduced | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 5,312 | $201.0K | 0.1% | +5,312 | New | History |
| NRIXNurix Therapeutics, Inc. | COM | 7,570 | $201.0K | 0.1% | +7,570 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 11,349 | $201.0K | 0.1% | +2,955+35.2% | Added | History |
| ATNXAthenex, Inc. | COM | 43,604 | $201.0K | 0.1% | +19,166+78.4% | Added | History |
| HARPHarpoon Therapeutics, Inc. | COM | 14,488 | $201.0K | 0.1% | −6,764−31.8% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 2,078 | $202.0K | 0.1% | −402−16.2% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 6,975 | $202.0K | 0.1% | +718+11.5% | Added | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 9,395 | $202.0K | 0.1% | +9,395 | New | History |
| CYTKCytokinetics Inc | COM NEW | 10,237 | $203.0K | 0.1% | −3,899−27.6% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 11,835 | $203.0K | 0.1% | +7+0.1% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 3,718 | $203.0K | 0.1% | −40−1.1% | Reduced | History |
| MRSNMersana Therapeutics, Inc. | COM | 14,912 | $203.0K | 0.1% | +3,141+26.7% | Added | History |
| TCRRTCR2 Therapeutics Inc. | COM | 12,379 | $203.0K | 0.1% | +1,696+15.9% | Added | History |
| ARVNArvinas, Inc. | COM | 2,655 | $204.0K | 0.1% | −2,496−48.5% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 30,600 | $204.0K | 0.1% | −2,003−6.1% | Reduced | History |
| ZYMEZymeworks Inc. | COM | 5,894 | $204.0K | 0.1% | +56+1.0% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 6,471 | $205.0K | 0.1% | −454−6.6% | Reduced | History |
| KRONKronos Bio, Inc. | COM | 8,554 | $205.0K | 0.1% | +8,554 | New | History |
| PASGPassage BIO, Inc. | COM | 15,459 | $205.0K | 0.1% | +15,459 | New | History |
| GOSSGossamer Bio, Inc. | COM | 25,361 | $206.0K | 0.1% | −3,102−10.9% | Reduced | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 18,201 | $206.0K | 0.1% | +18,201 | New | History |
| PGENPrecigen, Inc. | COM | 31,729 | $207.0K | 0.1% | −798−2.5% | Reduced | History |
| VanEck ETF Trust92189H409 | HIGH YLD MUNIETF | 3,250 | $207.0K | 0.1% | +3,250 | New | – |
| SPRYARS Pharmaceuticals, Inc. | COM | 6,701 | $207.0K | 0.1% | +6,701 | New | History |
| XNCRXencor Inc | COM | 5,992 | $207.0K | 0.1% | −551−8.4% | Reduced | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 37,977 | $207.0K | 0.1% | +12,204+47.4% | Added | History |
| TECXTectonic Therapeutic, Inc. | COM | 23,398 | $208.0K | 0.1% | +1,154+5.2% | Added | History |
| MRUSMerus N.V. | COM | 9,876 | $208.0K | 0.1% | +9,876 | New | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 7,479 | $209.0K | 0.1% | +7,479 | New | History |
| AMTIApplied Molecular Transport Inc. | COM | 4,565 | $209.0K | 0.1% | −4,859−51.6% | Reduced | History |
| ITOSiTeos Therapeutics, Inc. | COM | 8,134 | $209.0K | 0.1% | −1,958−19.4% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 7,692 | $210.0K | 0.1% | −2,610−25.3% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 2,530 | $210.0K | 0.1% | −1,476−36.8% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 4,734 | $210.0K | 0.1% | −627−11.7% | Reduced | History |
| ALLKAllakos Inc. | COM | 2,462 | $210.0K | 0.1% | −18−0.7% | Reduced | History |
| KDMNKadmon Holdings, Inc. | COM | 54,162 | $210.0K | 0.1% | −13,619−20.1% | Reduced | History |
| PRVBProvention Bio, Inc. | COM | 24,909 | $210.0K | 0.1% | +8,751+54.2% | Added | History |
| ARCTArcturus Therapeutics Holdings Inc. | COM | 6,229 | $211.0K | 0.1% | +3,444+123.7% | Added | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 10,765 | $211.0K | 0.1% | +826+8.3% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 3,992 | $212.0K | 0.1% | −1,827−31.4% | Reduced | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 49,819 | $212.0K | 0.1% | −23,418−32.0% | Reduced | History |
| BOLTBolt Biotherapeutics, Inc. | COM | 13,706 | $212.0K | 0.1% | +13,706 | New | History |
| CMRXChimerix Inc | COM | 26,472 | $212.0K | 0.1% | +26,472 | New | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 17,462 | $213.0K | 0.1% | +8,706+99.4% | Added | History |
| IMTXImmatics N.V. | SHS | 18,350 | $213.0K | 0.1% | −12,708−40.9% | Reduced | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 60,785 | $213.0K | 0.1% | +39,342+183.5% | Added | History |
Sold out since Q1 2021 (12)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| Five Prime Therapeutics Inc33830X104 | COM | 17,112 | $645.0K | 0.3% | – |
| KZRKezar Life Sciences, Inc. | COM | 54,313 | $324.0K | 0.1% | History |
| Eaton Vance FLTG Rate Incom278284104 | COM SHS BEN INT | 17,104 | $278.0K | 0.1% | – |
| Voya Prime Rate Tr92913A100 | SH BEN INT | 59,445 | $276.0K | 0.1% | – |
| OYSTOyster Point Pharma, Inc. | COM | 14,995 | $274.0K | 0.1% | History |
| NXTCNextCure, Inc. | COM | 24,419 | $244.0K | 0.1% | History |
| CNSTConstellation Pharmaceuticals Inc | COM | 9,500 | $222.0K | 0.1% | History |
| TCDATricida, Inc. | COM | 38,593 | $204.0K | 0.1% | History |
| VYGRVoyager Therapeutics, Inc. | COM | 35,712 | $168.0K | 0.1% | History |
| CALACalithera Biosciences, Inc. | COM | 61,161 | $148.0K | 0.1% | History |
| ODTOdonate Therapeutics, Inc. | COM | 19,421 | $66.0K | <0.1% | History |
| APREAprea Therapeutics, Inc. | COM | 10,454 | $53.0K | <0.1% | History |